Table 1 Summary of cohort and associated comorbidities
From: Genomic architecture of autism spectrum disorder in Qatar: The BARAKA-Qatar Study
| Â | Number of individuals (%) |
|---|---|
Sex | |
 Female | 16 (15.4%) |
 Male | 88 (84.6%) |
Additional clinical comorbidities | |
 ADHD | 37 (35.6%) |
 Intellectual disability | 31 (29.8%) |
 Developmental delay—speech | |
   Verbal | 96 (92.3%) |
   Non-verbal | 8 (7.7%) |
 Developmental delay—motor | 22 (21.1%) |
 Learning disabilities | 11 (10.6%) |
 Seizures | 7 (6.7%) |
 GI problem | 20 (19.2%) |